Trial
NCT06675513
Autologous CAR-T Cells (WD-01) for Metastatic Colorectal Cancer
Early Phase ISUSPENDEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Wondercel Biotech (ShenZhen)
Collaborators
—
Condition
CRC (Colorectal Cancer)
Intervention
An armored GCC targeting WD-01 CAR-T to treat cancer patients Other Name:
Why stopped
Because the implementation of the new regulation policy by the Chinese authority
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-05-07